• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高脂蛋白(a)水平与高 Killip 分级的急性心肌梗死患者的长期不良结局相关。

High Lipoprotein(a) Levels are Associated With Long-Term Adverse Outcomes in Acute Myocardial Infarction Patients in High Killip Classes.

机构信息

Heart Research Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University, Gwangju, Korea.

出版信息

Korean Circ J. 2010 Oct;40(10):491-8. doi: 10.4070/kcj.2010.40.10.491. Epub 2010 Oct 31.

DOI:10.4070/kcj.2010.40.10.491
PMID:21088752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2978291/
Abstract

BACKGROUND AND OBJECTIVES

An elevated concentration of lipoprotein(a) {Lp(a)} is associated with an increased prevalence and increased severity of coronary artery disease. However, the relationship between Lp(a) levels and outcomes after acute myocardial infarction (AMI) is unclear.

SUBJECTS AND METHODS

Between October 2005 and June 2007, we measured serum Lp(a) levels in 832 consecutive AMI patients (age, 62.8±12.4 years, 600 men) on admission. They were divided into tertiles according to their serum Lp(a) levels {Tertile 1 (n=276), Lp(a)<13.8 mg/dL; Tertile 2 (n=279), Lp(a)=13.8-30.6 mg/dL; Tertile 3 (n=277), Lp(a)>30.6 mg/dL}.

RESULTS

There were no differences in baseline clinical characteristics among Tertiles 1, 2, and 3, except for proportions of Killip class III-IV patients (5.8% vs. 10.0% vs. 18.8%, respectively, p<0.001). There were significant differences in left ventricular ejection fractions (57.3±11.4% vs. 55.9±12.3% vs. 53.1±13.1%, p<0.001). Among the laboratory findings, there were significant differences in total cholesterol (173.3±37.2 vs. 183.5±38.9 vs. 185.3±43.8 mg/dL, p=0.001), low density lipoprotein-cholesterol (111.3±34.3 vs. 122.9±34.7 vs. 123.3±39.4 mg/dL, p<0.001), apolipoprotein B (92.8±25.4 vs. 100.8±26.0 vs. 101.9±28.8 mg/dL, p<0.001), and amino-terminal pro-brain natriuretic peptide levels (1805.2±4343.3 vs. 2607.9±5216.3 vs. 3981.5±7689.7 pg/mL, p<0.001). After adjusting for multiple variables in the high Killip class (III-IV) subgroup, the risk estimate for major adverse cardiovascular events (MACE) at 1-year follow-up was significantly higher in Tertile 3 than in Tertiles 1 or 2 (hazard ratio 6.723, 95% confidence interval 1.037-43.593, p=0.046).

CONCLUSION

In patients in high Killip classes, high serum levels of Lp(a) were significantly associated with long-term adverse outcomes after AMI.

摘要

背景和目的

脂蛋白(a) [Lp(a)]浓度升高与冠状动脉疾病的患病率增加和严重程度增加有关。然而,Lp(a)水平与急性心肌梗死 (AMI) 后的结局之间的关系尚不清楚。

对象和方法

在 2005 年 10 月至 2007 年 6 月期间,我们在 832 例连续的 AMI 患者(年龄 62.8±12.4 岁,600 名男性)入院时测量了血清 Lp(a)水平。他们根据血清 Lp(a)水平分为三分之一{第 1 三分之一(n=276),Lp(a)<13.8mg/dL;第 2 三分之一(n=279),Lp(a)=13.8-30.6mg/dL;第 3 三分之一(n=277),Lp(a)>30.6mg/dL}。

结果

除了 Killip 分级 III-IV 的比例(分别为 5.8%、10.0%和 18.8%,p<0.001)外,Tertile 1、2 和 3 的基线临床特征无差异。左心室射血分数存在显著差异(分别为 57.3±11.4%、55.9±12.3%和 53.1±13.1%,p<0.001)。在实验室检查结果中,总胆固醇(173.3±37.2、183.5±38.9 和 185.3±43.8mg/dL,p=0.001)、低密度脂蛋白胆固醇(111.3±34.3、122.9±34.7 和 123.3±39.4mg/dL,p<0.001)、载脂蛋白 B(92.8±25.4、100.8±26.0 和 101.9±28.8mg/dL,p<0.001)和氨基末端脑钠肽前体水平(1805.2±4343.3、2607.9±5216.3 和 3981.5±7689.7pg/mL,p<0.001)存在显著差异。在高 Killip 分级(III-IV)亚组中调整多个变量后,第 3 三分之一的主要不良心血管事件(MACE)风险估计在 1 年随访时明显高于第 1 或第 2 三分之一(危险比 6.723,95%置信区间 1.037-43.593,p=0.046)。

结论

在高 Killip 分级的患者中,血清 Lp(a)水平升高与 AMI 后长期不良结局显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ca/2978291/02c4e880706d/kcj-40-491-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ca/2978291/5680a09f0602/kcj-40-491-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ca/2978291/02c4e880706d/kcj-40-491-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ca/2978291/5680a09f0602/kcj-40-491-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ca/2978291/02c4e880706d/kcj-40-491-g002.jpg

相似文献

1
High Lipoprotein(a) Levels are Associated With Long-Term Adverse Outcomes in Acute Myocardial Infarction Patients in High Killip Classes.高脂蛋白(a)水平与高 Killip 分级的急性心肌梗死患者的长期不良结局相关。
Korean Circ J. 2010 Oct;40(10):491-8. doi: 10.4070/kcj.2010.40.10.491. Epub 2010 Oct 31.
2
Impact of Lipoprotein (a) on Long-Term Outcomes in Patients With Acute Myocardial Infarction.载脂蛋白(a)对急性心肌梗死患者长期预后的影响。
Circ J. 2023 Sep 25;87(10):1356-1361. doi: 10.1253/circj.CJ-23-0221. Epub 2023 Jun 6.
3
Biphasic and monophasic pattern of brain natriuretic peptide release in acute myocardial infarction.急性心肌梗死时脑钠肽释放的双相和单相模式
Coll Antropol. 2011 Mar;35(1):155-9.
4
Lipid paradox in acute myocardial infarction-the association with 30-day in-hospital mortality.急性心肌梗死中的脂质悖论——与30天院内死亡率的关联
Crit Care Med. 2015 Jun;43(6):1255-64. doi: 10.1097/CCM.0000000000000946.
5
Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes.脂蛋白(a)升高对急性冠状动脉综合征患者的预后价值。
Eur J Clin Invest. 2019 Jul;49(7):e13117. doi: 10.1111/eci.13117. Epub 2019 May 7.
6
Short-term Prognosis of Fragmented QRS Complex in Patients with Non-ST Elevated Acute Myocardial Infarction.非ST段抬高型急性心肌梗死患者碎裂QRS波群的短期预后
Chin Med J (Engl). 2016 Mar 5;129(5):518-22. doi: 10.4103/0366-6999.176989.
7
Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels.脂蛋白(a)水平升高与正常低密度脂蛋白胆固醇水平的急性心肌梗死患者有关。
Biosci Rep. 2019 Apr 5;39(4). doi: 10.1042/BSR20182096. Print 2019 Apr 30.
8
Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention.脂蛋白(a)对经皮冠状动脉介入治疗后接受他汀类药物治疗的糖尿病患者长期临床结局的预后影响。
J Cardiol. 2020 Jul;76(1):25-29. doi: 10.1016/j.jjcc.2020.01.013. Epub 2020 Feb 20.
9
Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.PCSK9 抑制剂对脂蛋白(a)的降低作用与主要不良心血管事件:依洛尤单抗 3 期临床试验的汇总分析。
Atherosclerosis. 2019 Sep;288:194-202. doi: 10.1016/j.atherosclerosis.2019.06.896. Epub 2019 Jun 8.
10
Effect of Lipoprotein (a) Levels on Long-term Cardiovascular Outcomes in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries.脂蛋白(a)水平对非阻塞性冠状动脉心肌梗死患者长期心血管结局的影响。
Am J Cardiol. 2021 Aug 1;152:34-42. doi: 10.1016/j.amjcard.2021.05.003. Epub 2021 Jun 12.

引用本文的文献

1
The Association of Lipoprotein(a) with Major Adverse Cardiovascular Events after Acute Myocardial Infarction: A Meta-Analysis of Cohort Studies.急性心肌梗死后脂蛋白(a)与主要不良心血管事件的关联:队列研究的荟萃分析
Rev Cardiovasc Med. 2025 May 15;26(5):27376. doi: 10.31083/RCM27376. eCollection 2025 May.
2
High Lipoprotein(a) Levels as a Predictor of Major Adverse Cardiovascular Events in Hospitalized-Acute Myocardial Infarction Patients.高脂蛋白(a)水平作为住院急性心肌梗死患者主要不良心血管事件的预测指标
Vasc Health Risk Manag. 2020 Apr 8;16:125-132. doi: 10.2147/VHRM.S233503. eCollection 2020.
3
Prognostic value of lipoprotein (a) level in patients with coronary artery disease: a meta-analysis.

本文引用的文献

1
Differences in Clinical Outcomes Between Patients With ST-Elevation Versus Non-ST-Elevation Acute Myocardial Infarction in Korea.韩国 ST 段抬高与非 ST 段抬高型急性心肌梗死患者临床结局的差异。
Korean Circ J. 2009 Aug;39(8):297-303. doi: 10.4070/kcj.2009.39.8.297. Epub 2009 Aug 27.
2
Association of serum oxidized lipoprotein(a) concentration with coronary artery disease: potential role of oxidized lipoprotein(a) in the vasucular wall.血清氧化脂蛋白(a)浓度与冠状动脉疾病的关联:氧化脂蛋白(a)在血管壁中的潜在作用。
J Atheroscler Thromb. 2009 Aug;16(4):410-8. doi: 10.5551/jat.no224. Epub 2009 Aug 11.
3
Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.
脂蛋白(a)水平对冠心病患者预后的价值:一项荟萃分析。
Lipids Health Dis. 2019 Jul 8;18(1):150. doi: 10.1186/s12944-019-1092-6.
4
South Asian Cardiovascular Disease & Cancer Risk: Genetics & Pathophysiology.南亚心血管疾病和癌症风险:遗传学和病理生理学。
J Community Health. 2018 Dec;43(6):1100-1114. doi: 10.1007/s10900-018-0527-8.
5
Potential of lipoproteins as biomarkers in acute myocardial infarction.脂蛋白作为急性心肌梗死生物标志物的潜力。
Anatol J Cardiol. 2017 Jul;18(1):68-74. doi: 10.14744/AnatolJCardiol.2017.7403.
6
Association of lipoprotein(a) with long-term mortality following coronary angiography or percutaneous coronary intervention.脂蛋白(a)与冠状动脉造影或经皮冠状动脉介入治疗后的长期死亡率的关联。
Clin Cardiol. 2017 Sep;40(9):674-678. doi: 10.1002/clc.22712. Epub 2017 Apr 26.
7
The relationship between Lp(a) and CVD outcomes: a systematic review.脂蛋白(a)与心血管疾病结局之间的关系:一项系统综述。
Lipids Health Dis. 2016 May 17;15:95. doi: 10.1186/s12944-016-0258-8.
8
Factors affecting outcome of primary percutaneous coronary intervention for acute myocardial infarction.影响急性心肌梗死直接经皮冠状动脉介入治疗结果的因素。
ARYA Atheroscler. 2013 Jun;9(4):241-6.
妇女健康倡议研究之前激素治疗的患病率及观点:一项在四大洲开展的多国调查
J Womens Health (Larchmt). 2008 Sep;17(7):1151-66. doi: 10.1089/jwh.2007.0584.
4
Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.针对人载脂蛋白B-100的反义寡核苷酸可降低载脂蛋白(a)转基因小鼠中载脂蛋白(a)颗粒上的载脂蛋白(a)水平和氧化磷脂。
Circulation. 2008 Aug 12;118(7):743-53. doi: 10.1161/CIRCULATIONAHA.108.786822. Epub 2008 Jul 28.
5
Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study.普通人群中极高脂蛋白(a)水平与心肌梗死风险:哥本哈根城市心脏研究
Circulation. 2008 Jan 15;117(2):176-84. doi: 10.1161/CIRCULATIONAHA.107.715698. Epub 2007 Dec 17.
6
Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B.通过短期给予载脂蛋白B反义抑制剂有效降低载脂蛋白B和低密度脂蛋白胆固醇
Circulation. 2006 Oct 17;114(16):1729-35. doi: 10.1161/CIRCULATIONAHA.105.606442. Epub 2006 Oct 9.
7
Serum lipoprotein(a) level and clinical coronary stenosis progression in patients with myocardial infarction: re-revascularization rate is high in patients with high-Lp(a).心肌梗死患者的血清脂蛋白(a)水平与临床冠状动脉狭窄进展:高脂蛋白(a)患者的再次血管重建率较高。
Circ J. 2006 Feb;70(2):156-62. doi: 10.1253/circj.70.156.
8
Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis.缓释烟酸与洛伐他汀联合治疗高胆固醇血症的疗效:采用创新的表面图分析评估所有合理剂量
Arch Intern Med. 2004 May 24;164(10):1121-7. doi: 10.1001/archinte.164.10.1121.
9
Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions.美国国立心肺血液研究所脂蛋白(a)与心血管疾病研讨会报告:最新进展与未来方向
Clin Chem. 2003 Nov;49(11):1785-96. doi: 10.1373/clinchem.2003.023689.
10
Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis.老年女性中脂蛋白(a)与冠状动脉疾病的关系:年龄和性别分析
Atherosclerosis. 2000 Dec;153(2):445-51. doi: 10.1016/s0021-9150(00)00427-5.